These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 27083409)

  • 1. Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program.
    Fornaro R; Caratto M; Caratto E; Caristo G; Fornaro F; Giovinazzo D; Sticchi C; Casaccia M; Andorno E
    Clin Colorectal Cancer; 2016 Sep; 15(3):204-12. PubMed ID: 27083409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK; Rutter MD
    World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.
    Kim ER; Chang DK
    World J Gastroenterol; 2014 Aug; 20(29):9872-81. PubMed ID: 25110418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.
    Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; Fidder HH; Siersema PD; Dekker E; Oldenburg B
    Am J Gastroenterol; 2015 Jul; 110(7):1014-21. PubMed ID: 25823770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysplasia and cancer in inflammatory bowel disease.
    Basseri RJ; Basseri B; Papadakis KA
    Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):59-66. PubMed ID: 21309672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk.
    Herszényi L; Barabás L; Miheller P; Tulassay Z
    Dig Dis; 2015; 33(1):52-7. PubMed ID: 25531497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal Cancer Screening in Inflammatory Bowel Disease.
    Sengupta N; Yee E; Feuerstein JD
    Dig Dis Sci; 2016 Apr; 61(4):980-9. PubMed ID: 26646250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance strategies in inflammatory bowel disease.
    Schmidt C; Bielecki C; Felber J; Stallmach A
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):189-201. PubMed ID: 20485256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments.
    Clarke WT; Feuerstein JD
    World J Gastroenterol; 2019 Aug; 25(30):4148-4157. PubMed ID: 31435169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer in inflammatory bowel disease: review of the evidence.
    Keller DS; Windsor A; Cohen R; Chand M
    Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?
    Breynaert C; Vermeire S; Rutgeerts P; Van Assche G
    Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopy/surveillance in inflammatory bowel disease.
    Ahmadi AA; Polyak S
    Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease.
    Aalykke C; Jensen MD; Fallingborg J; Jess T; Langholz E; Meisner S; Andersen NN; Riis LB; Thomsen OØ; Tøttrup A
    Dan Med J; 2015 Jan; 62(1):B4995. PubMed ID: 25557336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updates in colorectal cancer screening in inflammatory bowel disease.
    Clarke WT; Feuerstein JD
    Curr Opin Gastroenterol; 2018 Jul; 34(4):208-216. PubMed ID: 29771698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant transformation in inflammatory bowel disease - surveillance guide.
    Stallmach A; Bielecki C; Schmidt C
    Dig Dis; 2009; 27(4):584-90. PubMed ID: 19897979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer surveillance in inflammatory bowel disease: the search continues.
    Ahmadi A; Polyak S; Draganov PV
    World J Gastroenterol; 2009 Jan; 15(1):61-6. PubMed ID: 19115469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease.
    Lutgens M; Vermeire S; Van Oijen M; Vleggaar F; Siersema P; van Assche G; Rutgeerts P; Oldenburg B;
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):148-54.e1. PubMed ID: 25041864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory bowel disease as a risk factor for colorectal cancer.
    Lukas M
    Dig Dis; 2010; 28(4-5):619-624. PubMed ID: 21088413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.